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Complement 5a (C5a) and Interleukin-17 (IL-17) are two important inflammatory media-
tors in sepsis. Here we studied the mechanisms underlying regulation of IL-17 by
anaphylatoxin C5a. We found that C5a blockade increased the survival rate of mice
following cecal ligation and puncture (CLP)-induced sepsis and decreased IL-17 expression
in vivo. IL-17 was secreted mainly by cd T cells in this model. Importantly, our data suggest
that C5a participates in the regulation of IL-17 secretion by cd T cells. Dendritic cells (DC)
were found to act as a ‘‘bridge’’ between C5a and cd T cells in a mechanism involving IL-6
and transforming growth factor b (TGF-b). These results imply that C5a affects the cross-
talk between DC and cd T cells during sepsis development, and this may result in a large
production of inflammatory mediators such as IL-17.
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Introduction
Sepsis is a life-threatening medical condition caused by various
microorganisms entering the human bloodstream and triggering
an uncontrolled inflammatory reaction. In light of the multi-
factorial pathogenesis of sepsis, extensive work has been done to
characterize the numerous agents and mediators that are
involved in sepsis. In spite of extensive research efforts over the
last 20 years, sepsis remains the leading cause of death in
intensive care units [1, 2]. Specific therapies are generally
unavailable because pathogenic mechanisms are still unclear.
There is abundant evidence that complement activation,
production of cytokines and other inflammatory responses occur
in sepsis [3]. It is generally accepted that the complement acti-
vation product complement 5a (C5a) plays an important
inflammatory role in rodents following cecal ligation and punc-
ture (CLP) [4]. C5a exerts its effects through the high-affinity C5a
receptor (C5aR) and C5L2. C5L2, a putative ‘‘default’’ receptor,
has been suggested to play important role in balancing the
biological effect of C5a. For example, recent data showed that
both C5aR and C5l2 cooperatively play functional parts in the
setting of sepsis [5]. It has been shown that blockade
of C5a or its receptor (C5aR) can inhibit the development
of CLP and is associated with decreased levels of bacteria,
preservation of innate immune functions of blood neutrophils,
reduced thymocyte apoptosis and greatly improved survival
rates [6, 7].
IL-17 (also known as IL-17A) is a proinflammatory cytokine
produced by a variety of cells including CD41 Th17 cells, CD81
T cells, neutrophils and NK cells [8]. Recent reports also
suggested that gd T cells are a major source of IL-17 [9]. Although
it has been demonstrated that IL-17 plays an important role in
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defense against extracellular pathogens such as Klebsiella pneu-
moniae [10], production and regulation of IL-17, interaction of
IL-17 with other critical pro-inflammatory cytokine in sepsis,
remain largely unclear.
Understanding crosstalk between critical pathogenic factors
may be very important for designing treatments for sepsis. Here,
we studied the crosstalk between two critical pathogenic factors,
C5a and IL-17. Our results show that C5a acted on DC, which
subsequently induced gd T cells to secrete IL-17.
Results
C5a induced IL-17 in CLP-induced sepsis
Sepsis models were made by cecal ligation and puncture. Here
both mild grade sepsis (with a survival rate of about 50%) and
high grade sepsis (with a survival rate of about 25%) models, as
described in the Materials and methods, were used. Unless
described otherwise, CLP mice referred to mice with high grade
sepsis. To prove the association between the critical inflammatory
cytokines C5a and IL-17 in CLP-induced sepsis, a polyclonal anti-
C5a antibody was developed and injected intravenously into CLP-
induced septic mice to assess its efficiency. Control animals
received a similar dose of nonspecific IgG antibody. The anti-C5a
antibody-treated mice showed significantly higher survival rates
compared with isotype IgG antibody-treated littermates
(p 5 0.046 Fig. 1A). These results indicate that anti-C5a
antibodies can treat sepsis effectively. When we examined IL-17
production in the anti-C5a antibody-treated CLP group, we found
that IL-17 significantly decreased 12 h after anti-C5a antibody
blockade, but did not decrease in the nonspecific IgG antibody
treated group (Fig. 1B), suggesting that C5a was involved in the
IL-17 production in CLP-induced sepsis.
IL-17 was secreted mainly by cd T cells in CLP-induced
sepsis
gd T cells act as an important source of IL-17 and have been
known to initiate innate immune responses [11, 12]. To explore
the origin of IL-17-secreting cells in CLP-induced sepsis, we first
isolated gd T cells from the splenocytes of sham and CLP mice.
We found that the capacity of gd T cells to release IL-17 was
significantly higher than those of non-gd T cells (Fig. 2A),
especially in CLP mice. Cell cytometry showed that IL-17 was
predominantly expressed in gd T cells (Fig. 2B), indicating that gd
T cells were a major source for IL-17 in CLP mice.
IL-17 plays an important pathogenic role in sepsis [9]. To
demonstrate the role of IL-17- expressing gd T cells in the
development of sepsis, here both mild grade sepsis and high
grade sepsis models were used. gd T cells were purified separately
from sham control and CLP mice (high grade sepsis), and then
transferred into mice with mild grade sepsis (with a survival rate
of about 50%). We found that gd T cells from the sham group
mice did not significantly affect the survival rate. Adoptive
transfer of gd T cells derived from CLP mice resulted in a
significant decrease in the survival rate in recipients, compared
with adoptive transfer of gd T cells derived from sham mice
(P 5 0.039, Fig. 3A). In addition to the capacity to
promote sepsis, gd T cells from CLP mice also secreted high levels
of IL-17, while gd T cells from sham mice only secreted a small
amount of IL-17 (Fig. 2A). These results demonstrate that high
levels of CLP-induced IL-17-secreting gd T cells play an important
pathogenic role.
We then evaluated the dynamic changes in gd T cells during
CLP-induced sepsis. Results showed that the percentage of gd
T cells in spleen was significantly elevated after CLP in compar-
ison with sham controls (Fig. 4A). In addition, the capacity of
gd T cells to secrete IL-17 was much stronger than that in sham
controls (Fig. 4B).
Figure 1. The effect of C5a blockade on IL-17 expression in CLP-
induced sepsis. (A). Animals received either 400mg of anti-C5a IgG (CLP
1anti-C5a) or preimmune IgG (CLP1preimmune IgG) intravenously
immediately after the CLP procedure. Sham animals underwent
laparotomy without CLP. Data are presented as survival rates (n 5 15/
group), which are representative of those for four independent
experiments. (B) Serum was obtained 12 h after sham surgery or CLP
in mice treated immediately at T0 with IgG antibodies against C5a
(anti-C5a) or preimmune IgG. IL-17A was measured by ELISA. Each
group consisted of 6mice. p-values were calculated with Kruskal–Wal-
lis H nonparametric test.
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C5a is involved in the regulation of IL-17 secretion by
cd T cells in CLP-induced sepsis
As CLP-induced IL-17-secreting gd T cells play an important
pathogenic role and C5a acts as an important mediator in IL-17
expression during sepsis, we postulated that C5a may affect the
function of gd T cells in CLP-induced sepsis, and that once C5a
was blocked, the gd T cells from the C5a blockade group would
lose their pathogenic role. gd T cells were collected from the anti-
C5a blockade group and were then transferred into a mild sepsis
model with a higher survival of 50%. The result showed that mice
that received gd T cells from anti-C5a-treated CLP mice had a
similar survival rate to mice that received gd T cells from sham
control, while the mice that received gd T cells from the
nonspecific IgG antibody-treated group had a significantly lower
survival rate. (P 5 0.042, Fig. 3B). Furthermore, the pathogenic
effect of gd T cells derived from CLP mice can also be abolished by
anti-C5a antibody (P 5 0.028, Fig. 3A). The data demonstrate
that the pathogenic role of gd T cells during CLP-induced sepsis
was associated with the production of C5a. In addition, blockade
of C5a reduced the capacity of gd T cells to secrete
IL-17 but did not affect the percentage and absolute number of
gd T cells in mice with CLP-induced sepsis (Fig. 4C and D). These
results suggest that C5a is directly or indirectly involved in IL-17
production from gd T cells in CLP-induced sepsis.
DC play an important role in C5a-mediated IL-17
production.
Whether C5a receptor (C5aR) is present on the surface of T cells is
also controversial. We postulated that the relationship between C5a
and gd T cells was indirect. As it has recently been shown that C5aR is
expressed on DC [13], DC may function as a bridge between C5a and
gd T cells. As shown in Fig. 5A, C5a significantly increased IL-17
production when T lymphocytes were co-cultured with DC. By
employing flow cytometric analysis, it was found that IL-17-producing
cells were mainly gd T cells in the cell population from the co-culture
and that C5a treatment doubled the number of IL-17-producing gd
T cells (Fig. 5B). These results suggest that DC are involved in the
regulation of IL-17 production by C5a. To further prove that DC
function as a bridge between C5a and IL-17-secreting gd T cells,
DCKO mice pretreated with diphtheria toxin (DT) (depletion of
CD11c1 DC) were used. The efficiency of DC depletion was 85.7% in
blood and 48% in spleen (data not shown). As shown in Fig. 6A, the
depletion of DC resulted in a sharp decline in the survival curve, and
anti-C5a treatment did not show any beneficial effect in the CLP
model using DC-depleted mice. Interestingly, DC depletion had a
direct influence on IL-17 levels in the circulation. As shown in Fig. 6B,
serum level of IL-17 was elevated in control mice after CLP and was
measurably lower in comparison to that in DC-depleted mice. These
results suggest that DC may play a pivotal role in IL-17 production.
Next, we studied the mechanisms underlying C5a induction of IL-17
secretion by DC. It is known that IL-6 and TGF-b can induce IL-17 in
Th17 cells. Here we found that C5a promotes IL-6 production by DC
(Fig. 7A); when anti-IL-6 and anti-TGF- blocking antibodies were
added to the co-culture of lymphocytes and DC, C5a-stimulated IL-17
production decreased markedly (Fig. 7B and C), while the isotype
control had no effect (data not shown), indicating that C5a-mediated
IL-17 production is partially dependent on IL-6 and TGF-b.
Discussion
This study demonstrates that gd T cells produce a large amount of
IL-17 in the CLP-induced sepsis model and that C5a can indirectly
modulate gd T cell-secretion of IL-17 in a DC-dependent manner.
Sepsis is a life-threatening medical condition caused by various
microorganisms entering the human bloodstream triggering an
uncontrolled inflammatory reaction. During the onset of sepsis, the
inflammatory system becomes hyperactive, involving both cellular
and humoral defense mechanisms. Endothelial and epithelial cells,
as well as neutrophils, macrophages and lymphocytes, produce
Figure 2. IL-17 secretion by purified gd T cells. Splenocytes were
collected from sham and CLP mice 12 h after the CLP operation, and gd
T cells were obtained from splenocytes by positive magnetic cell
sorting. (A) Purified positive gd T cells (gd1) and lymphocytes lacking gd
T cells (gdwere stimulated with rIL-23 (10 ng/mL) for 48 h. Amounts of
IL-17A in the supernatant were measured by ELISA. (B) Representative
plot showing the co-expression of IL-17 by purified gd T cells from
sham and CLP mice. Each experimental group consisted of four mice.
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powerful proinflammatory mediators. Simultaneously, humoral
defense mechanisms such as the complement system are activated,
resulting in production of proinflammatory mediators, including
C3a and C5a, which are powerful pathogenic mediators. Published
data provide compelling evidence for the beneficial effects of
blocking either C5a or C5aR (CD88) in experimental sepsis, which is
associated with attenuated coagulopathy, preservation of thymic
function, rescue of lymphocytes from apoptosis and reduced levels
of bacteremia [14–16].
Excessive IL-17 production has been detected in sera and target
tissues of patients with various autoimmune diseases, including
rheumatoid arthritis, multiple sclerosis, systemic lupus erythema-
tous and asthma [17]. However, evidence of the impact of IL-17 on
sepsis pathogenesis was quite contradictory. IL-17 may not only
mediate CpG-inducible host defense during intra-abdominal sepsis
[18], but may also play adverse functions in experimental sepsis [9].
Additionally, its prevalence and the mechanisms by which IL-17 is
generated and regulated in sepsis are unclear. In this report, we
found that blockade of C5a by anti-C5a polyclonal antibodies can
not only increase CLP survival rate but can also compromise IL-17
production; thus, C5a induced IL-17 in sepsis was confirmed.
IL-17 is a proinflammatory cytokine produced by a variety of
cells, including CD41 ab T cells, gd T cells, activated CD81 T cells,
neutrophils and NK cells. However, gd T cells are often an important
source of this cytokine. In contrast to conventional T cells, gd TCR-
bearing cells constitute only a small proportion (1–5%) of the
lymphocytes that circulate in the blood and peripheral organs [19],
but they are widespread within epithelia-rich tissues and provide
local regulation of inflammation. Regarding the source of IL-17 in
sepsis, we identified gd T cells as being an important source of IL-17
production in septic mice. After CLP operation, both the percentage
and IL-17 producing capacity of gd T cells increased significantly and
were much greater than those in the WT-type sham controls. Espe-
cially, at 24h after CLP operation, the IL-17 producing capacity of gd
T cells was much higher than at 120h. This difference may be due to
the natural process of sepsis in animals, with 24h representing the
acute phase. By 120h, those animals that survived the acute phase
demonstrated limited abscess formation (data not shown).
It has been shown that gd T cells can mitigate the organ injury
and mortality of sepsis [20]. But some studies on the role of gd T
cells in WT septic littermates have yielded divergent results, and it is
likely that gd T cells differentially regulate the inflammatory
response based on the type or site of infection. In our study, the role
of gd T cells in sepsis development was investigated by adoptive
transfer. In key published experimental sepsis papers, the survival
rate is almost between 20 and 25%. Here we used CLP mice with a
low survival rate (20%-25%) as the source of gd T cells because gd
T cells from such severe CLP-induced sepsis had a more powerful
capacity to secret IL-17. On the other hand, CLP mice with a higher
survival rate (50%) were used as the recipients to identify the
function of gd T cells. For future experiments, normal gd T cells and
IL-17-over-expressing gd T cells should be compared in function to
avoid any differences between the survival models used. It was
found that gd T cells derived from different animals have entirely
distinct functions. IL-17 over-expressing gd T cells are more patho-
genic, while normal gd T cells with minimal IL-17 production had no
detrimental effects. Interestingly, C5a blockade in vivo can influence
the capacity of gd T cells to secrete IL-17 but not the percentage and
absolute number of gd T cells. Most importantly, gd T cells derived
from the C5a blockade group lost their pathogenic role in adoptive
transfer. These results suggest an intimate link between C5a, gd
T cells and IL-17.
C5aR is widely expressed on myeloid cells, but whether it is
expressed on T cells, especially on gd T cells, was not clear
[21–23]. We assumed that the mechanism of C5a modulation
of gd T cells during sepsis might be indirect. Using FACS
analysis, we showed that C5aR is expressed on DC. In addition,
IL-17 production is significantly elevated in the presence of
Figure 3. IL-17-overexpressing gd T cells contribute to CLP. (A) CLP-induced gd T cells have the pathogenic role function. gd T cells (1.5 106) were
isolated from sham or CLP group and then transferred into recipient CLP mice with survival rate of 50% for the mild sepsis procedure. Furthermore,
400 mg of anti-C5a IgG were given intravenously immediately after gd T cells (1.5 106) from CLP group were transferred into recipient. Not-
transferred CLP mice were used as controls. Each experimental group consisted of 20 mice. (B) C5a blockade cancelled the pathogenic role of gd
T cells in CLP. gd T cells (1.5 106) were isolated from anti-C5a or nonspecific IgG antibody-treated CLP mice and then transferred into recipient CLP
mice with survival rate of 50% for the mild sepsis procedure). gd T cells from the sham mice transfer group were used as controls. Each
experimental group consisted of 20 mice.
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recombinant mouse C5a in the co-culture of DC and T lympho-
cytes, and the depletion of DC in vivo markedly dwarfed serum
levels of IL-17. These results suggest an important role for DC as
intermediate for C5a modulation of IL-17 production. It is
believed that DC determined the fate of the immune response
during infection. Using CD11c–knockout mice, it has been
demonstrated that maintaining DC numbers or functions may
improve sepsis survival [24]. The discrepancy that naturally
arises from these data is that loss of CD11c1 DC on the one hand
results in dramatic reductions in pathogenic IL-17, while on the
other hand it leads to decreased survival. An alternative expla-
nation is that the environment DC encountered might determine
Figure 4. Effects of C5a blockade on gd T cells during sepsis. (A) Purified gd T cells from splenocytes were taken from CLP mice or sham controls at
24 and 120 h. Percentages represent the means7SD of three different experiments. (B) Purified gd T cells from different groups of mice were
stimulated with rIL-23(10 ng/mL) for 48 h, and the resulting IL-17A content in culture supernatants was measured by ELISA. One set of three
repeated experiments is shown, where each experimental group consisted of four or five mice. (C) Percentage increase of gd T cells in CLP mice
with intravenous infusion of anti-C5a antibody and preimmune IgG. Values represent the means7SD of three different experiments. (D)Absolute
numbers of gd T cells were obtained separately from the sham, anti-C5a antibody and preimmune IgG-treated group after purification. Values
represent the means7SD of three different experiments. (E) Purified gd T cells from antibody-treated mice were stimulated with rIL-23 (10 ng/mL)
for 48 h, and the resulting IL-17A levels in the culture supernatants were measured by ELISA. Data are representative of three independent
experiments. Each experimental group consisted of five mice. (F) Representative plot showing the co-expression of IL-17 by purified gd T cells from
the sham, anti-C5a or nonspecific IgG antibody-treated group. Each experimental group consisted of four mice. p-values were calculated with
Kruskal–Wallis H nonparametric test.
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its function. In normal condition, DC are professional antigen-
presenting cells and play a guarding role in the immune system.
But in septic condition, C5a treatment driven them prone to
inflammatory DC, served as a mediator for IL-17 production.
Th cells producing IL-17 (Th17 cells) are a distinct subset of
effector cells that differentiate from naive T cells in response to IL-6
and TGF-b [25, 26], whereas IL-23 serves as an important factor to
expand previously differentiated Th17 cell populations and gd
T cells [27, 28]. Our data showed that C5a significantly increased
IL-17 production by T lymphocytes in the presence of DC, while it
had no influence on IL-17 production from T lymphocyte when DC
were absent. This effect depended partially on the soluble cytokines,
IL-6 and TGF-b, which are likely secreted by DC. How DC regulate
the function of gd T cells and how C5a influences the process are
largely unknown. In addition to IL-6 and TGF-b, other mediators
and/or cell-cell interactions may be involved. This line of research is
currently under investigation.
In summary, we have shown that gd T cells can release a large
amount of IL-17 during experimental sepsis in a C5a-dependent
manner and that IL-17-secreting gd T cells play an important role in
the pathogenesis of sepsis. DC appear to function as a bridge in C5a
and gd T cells for IL-17 production, a process dependent on IL-6 and
TGF-b. These in vitro and in vivo data provide a strong evidence, for
the first time, that C5a mediates IL-17 production from gd T cells
through DC during experimental sepsis. This study adds a new
dimension for the research of pathogenic mechanisms in sepsis.
Materials and methods
Mice
Seven to eight-wk-old male C57BL/6 mice and conditional
DC knockout mice B6.FVB-Tg (Itgax-DTR/EGFP)57Lan/J
mice were obtained from the Jackson laboratory (Bar
Harbor, ME, USA) and bred in our facilities under specific
pathogen-free conditions. All treatment of mice in this study was
in strict agreement with guidelines on the care and use of
laboratory animals set out by the Institute of Basic Medical
Sciences.
Production of anti-C5a antibody
The C-terminal end of mouse C5a (sequence: CTIANKIR-
KESPHKPVQLGR) corresponding to amino acids 58–77 was
Figure 5. C5a regulation of DC-mediated IL-17 production. (A)
T lymphocytes from mesenteric and groin nodes were co-cultured
with DC for 3 days, C5a and anti-CD3 antibodies were added to the
media and supernatants were collected for ELISA. Means and SD of
IL-17 production after cell co-culture are shown for each group of six
individuals. (C) Flow cytometric analysis of gd TCR-FITC and IL-17-PE
staining in T cells from DC and T lymphocyte co-cultures stimulated
with C5a. Data are representative of three separate experiments.
p-values were calculated with Kruskal–Wallis H nonparametric test.
Figure 6. IL-17 in gd T cells decreased in CLP-induced DCKO mice.
(A) CD11c1 DC depletion leads to high lethality of CLP. Survival was
determined in DCKO versus WT littermates following the injection of
DT (8ng/g body weight) 20 h before the induction of CLP. Antibodies
against C5a or preimmune IgG isotype were administered immediately
after the CLP operation. Data are presented as percentage survivals
(n 5 13/group). (B) Serum was obtained from mice 24 h after CLP
operations, and IL-17A was measured by ELISA. Each group consisted
of at least six mice. p-values were calculated with Kruskal–Wallis H
nonparametric test.
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chosen for peptide synthesis. The peptide was coupled to keyhole
limpet and used for the immunization of rabbits and production
of anti-C5a. The polyclonal antibody was purified by protein A
chromatograph, and its reactivity with recombinant mouse C5a
(Hycult biotechnology b.v, uden, The Netherlands) was
confirmed by ELISA.
Depletion of DC
To deplete CD11c1 DC, DCKO mice were treated with an i.p.
injection of 8 ng/g body weight of DT (Sigma-Aldrich, St. Louis,
MO, USA). As controls, DCKO mice were i.p. injected with saline
vehicle alone. Eighteen to 20 h after i.p. injections, mice under-
went CLP operations or were sacrificed for harvesting of spleen
and blood samples.
Induction of sepsis by CLP
Specific pathogen-free 7-8 week old male B6.FVB-Tg (Itgax-
DTR/EGFP) 57Lan-J mice treated with DT 18 to 20 h before
CLP operations and C57BL/6 mice were used for studies
as indicated. Sepsis was induced by Cecal Ligation and
Puncture (CLP) and severity of sepsis was highly dependent
on the extent of cecal ligation. Here both mild-grade sepsis and
high-grade sepsis were used in our experiments as described
(29). Briefly, for the induction of mild-grade sepsis, which
resulted in survival rates of 50%, the cecum is ligated at half
the distance between distal pole and the base of the cecum. While
high-grade sepsis (25% survival rates) involves ligation of 75% of
the cecum. After the bowel was repositioned, the abdomen was
closed in layers, using a 4.0 surgical suture and metallic clips.
Sham-operated mice were handled in the same manner, except
that the cecum was not ligated and punctured. After CLP
operations, the animals received 400 g of anti-C5a IgG in 400 l
Dulbecco’s phosphate buffered saline solution (DPBS) intrave-
nously immediately after CLP. Control animals received similar
amounts of normal rabbit IgG (Jing Mei Biotechonogy, Beijing,
China).
Adoptive transfer
For adoptive transfer, gd T cells purified from splenocytes by
MACS from sham controls, anti-C5a-treated and nonspecific IgG
antibody-treated CLP mice were transfused into recipient mice
with each mouse receiving 1.5106 gd T cells. Recipient CLP
mice were used as controls. To effectively reflect the role of gd
T cells, we employed a mild sepsis model for this study. During
CLP procedure, 1/3 instead of 2/3 of cecum was ligated, and the
rest of CLP procedure are similar.
Collection of serum samples
After induction of sepsis, animals were sacrificed after
CLP or sham operations, and blood was drawn from the inferior
vena cava. Blood samples were allowed to clot at room
Figure 7. C5a-activated DC induced IL-17 production from T lympho-
cytes via IL-6 and TGF-b. (A) Effects of C5a on IL-6 production
by DC was determined by ELISA assay 3 days after C5a was
added to DC. Data are shown as means7SD. (B) Effects of neutralizing
anti-IL-6 or anti-TGF-b, or a mixture of both mAb, on IL-17 production,
were determined by ELISA in DC cultures in the presence of
C5a and T lymphocytes. T lymphocytes and DC were co-cultured
with anti-IL-6 and anti-TGF-b antibodies. On day 3, the co-cultured
supernatant was collected and IL-17 levels were evaluated. Data
are representative of three separate experiments. All data are
presented as means7SD. (C) IL-17 expression in gdT after
treatment with anti-IL-6, anti-TGF-b or both. FACS profiles show
the percentage of IL-171gd T cells among gated CD31gd1 T cells.
The data shown are representative of those for three independent
experiments. p-values were calculated with Kruskal–Wallis H nonpara-
metric test.
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temperature and were centrifuged at 5000 rpm for 10 min. Serum
was collected and frozen immediately at 801C until used for
ELISA analysis.
In vitro generation of DC from bone marrow
Mice were sacrificed and all muscle tissues were removed with
gauze from the femurs. Bones were placed in a 50-mm dish with
75% alcohol for 1 min, washed twice with PBS and transferred
into a fresh dish with PBS. Both ends of the bones were cut with
scissors, and the tissue was suspended and passed through a
nylon mesh to remove small pieces of bone and debris. The cell
suspension was centrifuged and washed twice with RPMI 1640
supplemented with 10% FBS, 50 mM 2-ME, 100 U/mL penicillin,
100mg/mL streptomycin (all from Gibco, Grand Island, NY,
USA). Aggregates were cultured in fresh medium with GM-CSF
(R&D Systems, Minneapolis, MN, USA) in 6-well plates (Corning
Costar, Corning, NY, USA) at a cell density of 1 107/mL/well.
After 4 days of culture, large numbers of typical DC were
released. The supernatant was then discarded and the medium
was refreshed by adding new GM-CSF for subsequent experi-
ments.
In vitro induction of T lymphocyte secretion of IL-17
DC derived from bone marrow were cultured in vitro. On day 5,
1 107 T lymphocytes from mesenteric and inguinal lymph
nodes, anti-CD3 antibody (0.05 mg/mL, clone 145-2C11,
eBioscience, San Diego, CA, USA) and/or recombinant mouse
C5a (100nM) were added to the cultured DC. After another 3
days of co-culture, supernatants were collected for ELISA assay.
Detection of cytokine, IL-6 and TGF- production by DC
via C5a stimulation
Briefly, 5 days after typical DC were obtained, recombinant
mouse C5a (100 nM) was added to the culture, and after
incubation for 3 days, cell-culture supernatants were collected
for ELISA assay of IL-23, IL-6 and TGF-b.
Anti-IL-6 and anti-TGF-b Antibodies
Anti-IL-6 antibodies (1.8 ng/mL, antigen:antibody (M) 5 1:2)
(R&D, Clone MP520F3) and anti-TGF-b antibodies (14 ng/mL,
antigen:antibody (M) 5 1:2) ((R&D, Clone MAB1835) were
added to the DC-cell and T-cell co-cultures immediately after
anti-CD3 antibodies (0.05mg/mL) and C5a (100 nM) stimulation.
Same dose of rat IgG1 (R&D, Clone MAB005) and mouse IgG1
(R&D, Clone MAB002) antibodies were separately used as isotype
control. Supernatants were collected after 3 days for assaying
IL-17 production.
Isolation of cd T cells
gd T cells were sorted from mice splenocytes according to the
manufacturer’s protocol. Briefly, spleens were collected and
lymphocytes were enriched by Ficoll-Hypaque (Pharmacia,
Uppsala, Sweden). Lymphocytes were washed twice with PBS
buffer containing 0.5% BSA and 2 mM EDTA. For 1107 cells,
50 mL PBS buffer and 5mL PE-conjugated anti-gd T antibody
(clone GL3, eBioscience) were added and incubated at 41C for
10 min. Subsequently, unconjugated antibodies were washed
twice with PBS buffer and cells were re-suspended in 50 mL buffer
per 1 107 cells. Ten-microliter anti-PE-Microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany) was added and incubated
at 41C for 15 min. Finally, after two washes, cells were sorted
using MACS Separator columns (Miltenyi Biotec) and separated
into bound and un-bound fractions. The positive fraction was
collected and purity was measured by flow cytometry. Data
collection and analysis were performed on a FACScaliber flow
cytometer using CellQuest software (Becton Dickinson, San Jose,
CA, USA).
Cytometric analysis and intracellular cytokine staining
Ex vivo intracellular cytokine staining was performed, as previously
reported. Briefly, 1mg/mL brefeldin A, 50 ng/mL PMA and 1mg/mL
Ionomycin (all from Sigma-Aldrich) were added for the final 5–6 h
of the incubation period. T lymphocytes incubated with DC were
collected and stained with PE-conjugated anti-IL-17 (BD Bio-
sciences, San Jose, CA, USA) and FITC-conjugated anti-gdTCR
(eBioscience), while gd T cell positives and negatives were stained
with PE-conjugated anti-gdTCR (eBioscience) and FITC-conjugated
anti-IL-17 (BD Biosciences). Cell were stained in PBS with 2% heat-
inactivated FBS and 0.2% sodium azide and fixed using PBS with
1% paraformaldehyde. For intracellular staining, cells were first
stained with antibodies specific to gd TCR for 30 min and then fixed
for 20 min with 1 mL fixation buffer (Fix and Perm cell
permeabilization kit, eBioscience). After washing, the fixed cells
were incubated with anti-mouse-IL-17 antibody for 30 min. PE-
conjugated anti-CD88 (Abcam, Camdridge, UK) and FITC-conju-
gated anti-gdTCR (eBioscience) were used to detect C5aR expres-
sion on gd T cells. Data collection and analysis were performed on a
FACS Calibur flow cytometer using CellQuest software.
Cytokine analysis by ELISA
The concentration of IL-6, IL-17A and TGF-b1 was measured by
ELISA kits (eBioscience). Absorbance was measured on an
automatic plate reader. For measurement of the IL-17A level
secreted by gd T cells, bound and un-bound fractions collected
after column separation were seeded into round-bottomed
96-well plates (Costar). Cytokine IL-23 (10 ng/mL) (R&D) was
added, and supernatants were collected after 2 days for ELISA
analysis.
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Statistical analysis
Data analysis was performed with SPSS version 13.0 for Windows
software (SPAA, Chicago, IL, USA) and expressed as mean7SD
for percentages. Significance of difference between the two
groups was determined by applying the Mann–Whitney nonpara-
metric U test. Multiple comparisons with Kruskal–Wallis H
nonparametric test was applied with Bonferroni step-down
(Holm) correction. Actuarial overall survival rates were analyzed
by the Kaplan–Meier method. Values of po0.05 were considered
significant.
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